Related Experiment Video

Updated: Oct 23, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K

MicroRNAs in Huntington's Disease: Diagnostic Biomarkers or Therapeutic Agents?

Xiaoyu Dong1, Shuyan Cong1

  • 1Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China.

Frontiers in Cellular Neuroscience
|August 23, 2021
PubMed

Insights

MicroRNAs (miRNAs) are small molecules crucial for nervous system function. Dysregulated miRNAs are implicated in Huntington's disease (HD), showing potential as biomarkers and therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small, non-coding RNA molecules regulating gene expression.
  • miRNAs are vital for nervous system development, differentiation, and function.
  • Aberrant miRNA expression is linked to neurodegenerative diseases, notably Huntington's disease (HD).

Purpose of the Study:

  • To review the role of dysregulated miRNAs in Huntington's disease (HD).
  • To explore the potential of miRNAs as biomarkers for HD.
  • To discuss miRNAs as possible therapeutic targets for HD.

Main Methods:

  • Literature review of recent studies on miRNAs and HD.
  • Analysis of miRNA biogenesis and function in the nervous system.
  • Examination of pathophysiological implications of miRNA dysregulation in HD.

Main Results:

  • miRNAs are key regulators in neuronal function and development.
  • Specific miRNA expression patterns are altered in Huntington's disease.
  • miRNAs demonstrate potential as diagnostic biomarkers for HD.
  • miRNAs offer promising avenues for novel therapeutic strategies in HD.

Conclusions:

  • Dysregulated miRNAs are significantly involved in the pathology of Huntington's disease.
  • miRNAs hold considerable promise as both biomarkers and therapeutic targets for HD.
  • Further research into miRNA mechanisms in HD could lead to effective treatments.
Keywords:
Huntington’s diseasebiomarkerdiagnosismicroRNAtherapy

More Related Videos

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation13:36

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation

Published on: July 23, 2012

19.6K
Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections07:55

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

581

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.3K